FDA Inspection 1216777 — Oishi Koseido Co., Ltd.

Oishi Koseido Co., Ltd. — FEI 3010166685

The FDA completed an inspection of Oishi Koseido Co., Ltd. on Sep 1, 2023 in Tosu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tosu (Japan)

Citations

IDCFRDescription
127021 CFR 211.68(b)input/output verification
149621 CFR 211.122(a)Sampling/testing of labeling/packaging materials
191421 CFR 211.166(a)Lack of written stability program
197521 CFR 211.182Written records kept in individual logs
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
363221 CFR 211.170(b)Annual visual exams of drug products

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.